Shanghai RAAS nears completion of share buyback plan

Shanghai RAAS Blood Products Co., Ltd. has announced substantial progress on its share repurchase program as of September 30, 2025. The company has cumulatively repurchased 68,321,952 shares, representing 1.03% of its total share capital. The aggregate transaction value for these repurchases amounts to 469,849,037.98 yuan, excluding transaction commissions and other fees.

The repurchases were executed at a highest transaction price of 7.09 yuan per share and a lowest transaction price of 6.62 yuan per share. This activity is in line with the company's previously approved share repurchase plan and relevant regulations.

The board of directors approved the repurchase plan on January 13, 2025, with an initial budget of no less than 250 million yuan and no more than 500 million yuan, at a maximum price of 9.55 yuan per share. The company intends to use the repurchased shares for employee stock ownership plans or equity incentives. Shanghai RAAS will continue to implement the repurchase plan and provide timely disclosures.